NO20021718L - Substituerte pyrroler som antiproliferative midler for behandling av kreft - Google Patents

Substituerte pyrroler som antiproliferative midler for behandling av kreft

Info

Publication number
NO20021718L
NO20021718L NO20021718A NO20021718A NO20021718L NO 20021718 L NO20021718 L NO 20021718L NO 20021718 A NO20021718 A NO 20021718A NO 20021718 A NO20021718 A NO 20021718A NO 20021718 L NO20021718 L NO 20021718L
Authority
NO
Norway
Prior art keywords
cancer
treatment
antiproliferative agents
pyrrols
substituted
Prior art date
Application number
NO20021718A
Other languages
English (en)
Other versions
NO20021718D0 (no
Inventor
Nader Fotouhi
Norman Kong
Emily Aijun Liu
Allen John Lovey
Jr John Guilfoyle Mullin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20021718L publication Critical patent/NO20021718L/no
Publication of NO20021718D0 publication Critical patent/NO20021718D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20021718A 1999-10-12 2002-04-11 Substituerte pyrroler som antiproliferative midler for behandling av kreft NO20021718D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15886099P 1999-10-12 1999-10-12
PCT/EP2000/009635 WO2001027106A1 (en) 1999-10-12 2000-10-02 Substituted pyrroles as antiproliferative agents for the treatment of cancer

Publications (2)

Publication Number Publication Date
NO20021718L true NO20021718L (no) 2002-04-11
NO20021718D0 NO20021718D0 (no) 2002-04-11

Family

ID=22570037

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021718A NO20021718D0 (no) 1999-10-12 2002-04-11 Substituerte pyrroler som antiproliferative midler for behandling av kreft

Country Status (30)

Country Link
EP (1) EP1224181B1 (no)
JP (1) JP2003511449A (no)
KR (1) KR20020038817A (no)
CN (1) CN1155595C (no)
AR (1) AR026004A1 (no)
AT (1) ATE255576T1 (no)
AU (1) AU781732B2 (no)
BR (1) BR0014680A (no)
CA (1) CA2385071A1 (no)
CZ (1) CZ20021610A3 (no)
DE (1) DE60006990T2 (no)
DK (1) DK1224181T3 (no)
ES (1) ES2210005T3 (no)
HK (1) HK1050533A1 (no)
HR (1) HRP20020262B1 (no)
HU (1) HUP0203558A3 (no)
IL (1) IL148815A0 (no)
MA (1) MA26830A1 (no)
MX (1) MXPA02003667A (no)
NO (1) NO20021718D0 (no)
NZ (1) NZ518038A (no)
PE (1) PE20010695A1 (no)
PL (1) PL357441A1 (no)
PT (1) PT1224181E (no)
RU (1) RU2002110111A (no)
TR (1) TR200200987T2 (no)
TW (1) TWI230708B (no)
WO (1) WO2001027106A1 (no)
YU (1) YU25202A (no)
ZA (1) ZA200202231B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US7776855B2 (en) 2006-07-27 2010-08-17 Janssen Pharmaceutica N.V. Antimicrobial oxazolidinone prodrugs
JP5732453B2 (ja) * 2009-06-25 2015-06-10 アルカーメス ファーマ アイルランド リミテッド Nh酸性化合物のプロドラッグ
UY34072A (es) 2011-05-17 2013-01-03 Novartis Ag Derivados sustituidos de indol
KR20150079665A (ko) 2012-11-07 2015-07-08 노파르티스 아게 치환된 인돌 유도체
EP3771711A1 (en) 2019-07-29 2021-02-03 Bayer Animal Health GmbH Pyrazole derivatives for controlling arthropods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
ES2203111T3 (es) * 1998-03-17 2004-04-01 F. Hoffmann-La Roche Ag Maleimidas bisindol sustituidas para la inhibicion de proloferacion celular.

Also Published As

Publication number Publication date
AU781732B2 (en) 2005-06-09
YU25202A (sh) 2004-12-31
HUP0203558A3 (en) 2004-01-28
DE60006990D1 (de) 2004-01-15
EP1224181A1 (en) 2002-07-24
EP1224181B1 (en) 2003-12-03
DE60006990T2 (de) 2004-10-28
CN1378545A (zh) 2002-11-06
HUP0203558A2 (hu) 2003-02-28
MXPA02003667A (es) 2002-08-30
ZA200202231B (en) 2003-06-19
HK1050533A1 (en) 2003-06-27
TR200200987T2 (tr) 2002-09-23
ATE255576T1 (de) 2003-12-15
TWI230708B (en) 2005-04-11
HRP20020262A2 (en) 2004-04-30
IL148815A0 (en) 2002-09-12
CA2385071A1 (en) 2001-04-19
WO2001027106A1 (en) 2001-04-19
PT1224181E (pt) 2004-04-30
CZ20021610A3 (cs) 2002-10-16
ES2210005T3 (es) 2004-07-01
CN1155595C (zh) 2004-06-30
HRP20020262B1 (en) 2005-06-30
KR20020038817A (ko) 2002-05-23
AU7911600A (en) 2001-04-23
RU2002110111A (ru) 2003-12-20
NO20021718D0 (no) 2002-04-11
DK1224181T3 (da) 2004-04-13
NZ518038A (en) 2004-02-27
MA26830A1 (fr) 2004-12-20
JP2003511449A (ja) 2003-03-25
AR026004A1 (es) 2002-12-26
PL357441A1 (en) 2004-07-26
BR0014680A (pt) 2002-06-11
PE20010695A1 (es) 2001-07-05

Similar Documents

Publication Publication Date Title
EE200200172A (et) Ühendid isheemia ravimiseks
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
DE60009147T2 (de) Admantan derivate
EE05481B1 (et) Kinasoliini derivaadid kasvajate raviks
PT1210113E (pt) Composicoes de vacinas de combinacao
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
FI20000863A (fi) Uusi hoitomenetelmä
NO20034780L (no) Antiangiogenisk kombinasjonsterapi for behandling av kreft
NO20040516L (no) Kombinasjonsterapi for behandling av kreft.
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
ATE273962T1 (de) 5-phenyl-pyrimidine derivate
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
DK1176964T3 (da) Brug af ET743 til behandling af cancer
NO20020358D0 (no) Anvendelse av etodolac for behandling av kreft
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20014926L (no) Farmasöytiske forbindelser
ATE317389T1 (de) 4-phenyl-pyrimidine derivate
ID29533A (id) Senyawa-senyawa kalsilitik
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
NO20021718L (no) Substituerte pyrroler som antiproliferative midler for behandling av kreft
NO20033341D0 (no) Metoder for administrering av epothilone-analoger for behandling av kreft
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20013385D0 (no) S-nitrosotioler som midler for behandling av sirkulatoriske dysfunksjoner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application